RE:RE:RE:RE:RE:RE:Odds....(same posting without all the typos...)
It takes at least two things for a company to be successfull...
a good or visionary product and a good business/sales team.
I bought shares of PMED because I speculated (speculated - not invested!) that the result of their 3000 people impairment studies in India would proove their technology. I had doubts wrt the business part of the story. I have become rather critical when they started the cooperation with Juiceworks and nothing came out of it, although their Covid-19 scanners should have been in high demand if working properly. I also wondered why - if everything was really as rosy as promised - no company with big pockets took them out (PMED could easily be swallowed by one of the big Indian companies who already know all the results of the trials). Half a year later we still have not heard anything from these 3000 people trials (results are actually long overdue) and except for promises (paid reports, interviews and presentations to internet outlets, distribution agreements) we didn't hear much about revenues, not to mention earnings. The result is a frustrated shareholder base (except for some promoters whose motives cannot be evaluated) and a seriously declining share price.
NEVERTHELSS, if the technology works and can be deployed at a reasonable price, PMED will be a big winner and the share price will reach several bucks. Hence I hold my position, but watch closely.
L.